Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 1240843, 5 pages
http://dx.doi.org/10.1155/2016/1240843
Research Article

GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance

1Department of Endocrinology and Metabolism, Gazi University Faculty of Medicine, 06560 Ankara, Turkey
2Department of Biochemistry, Gazi University Faculty of Medicine, 06560 Ankara, Turkey
3Department of Internal Medicine, Gazi University Faculty of Medicine, 06560 Ankara, Turkey

Received 24 March 2016; Revised 20 June 2016; Accepted 2 August 2016

Academic Editor: Ed Randell

Copyright © 2016 Mehmet Muhittin Yalcin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. N. Rajpathak, J. P. Crandall, J. Wylie-Rosett, G. C. Kabat, T. E. Rohan, and F. B. Hu, “The role of iron in type 2 diabetes in humans,” Biochimica et Biophysica Acta—General Subjects, vol. 1790, no. 7, pp. 671–681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. T.-P. Tuomainen, K. Nyyssönen, R. Salonen et al., “Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men,” Diabetes Care, vol. 20, no. 3, pp. 426–428, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Nemeth, M. S. Tuttle, J. Powelson et al., “Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization,” Science, vol. 306, no. 5704, pp. 2090–2093, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Zaritsky, B. Young, H.-J. Wang et al., “Hepcidin—a potential novel biomarker for iron status in chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 6, pp. 1051–1056, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Arezes and E. Nemeth, “Hepcidin and iron disorders: new biology and clinical approaches,” International Journal of Laboratory Hematology, vol. 37, supplement 1, pp. 92–98, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Martinelli, M. Traglia, N. Campostrini et al., “Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study,” PLoS ONE, vol. 7, no. 10, Article ID e48250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. H. L. Cheng, C. E. Bryant, K. B. Rooney et al., “Iron, hepcidin and inflammatory status of young healthy overweight and obese women in Australia,” PLoS ONE, vol. 8, no. 7, Article ID e68675, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Przybyszewska, E. Zekanowska, K. Kȩdziora-Kornatowska et al., “Comparison of serum prohepcidin and iron metabolism parameters in obese and non-obese elderly individuals,” Endokrynologia Polska, vol. 64, no. 4, pp. 272–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Gözdemir, I. Kaygusuz, and H. Kafali, “Is hepcidin a new cardiovascular risk marker in polycystic ovary syndrome?” Gynecologic and Obstetric Investigation, vol. 75, no. 3, pp. 196–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. H. Sam, M. Busbridge, A. Amin et al., “Hepcidin levels in diabetes mellitus and polycystic ovary syndrome,” Diabetic Medicine, vol. 30, no. 12, pp. 1495–1499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Luque-Ramírez, F. Álvarez-Blasco, M. Alpañés, and H. F. Escobar-Morreale, “Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 3, pp. 846–852, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Aso, K. Takebayashi, S. Wakabayashi et al., “Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 90, no. 3, pp. 250–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Guo, D. Zhou, P. An et al., “Associations between serum hepcidin, ferritin and Hb concentrations and type 2 diabetes risks in a Han Chinese population,” The British Journal of Nutrition, vol. 110, no. 12, pp. 2180–2185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Tanno, N. V. Bhanu, P. A. Oneal et al., “High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin,” Nature Medicine, vol. 13, no. 9, pp. 1096–1101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. R. Bootcov, A. R. Bauskin, S. M. Valenzuela et al., “MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 21, pp. 11514–11519, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Kempf, A. Guba-Quint, J. Torgerson et al., “Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial,” European Journal of Endocrinology, vol. 167, no. 5, pp. 671–678, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Karczewska-Kupczewska, I. Kowalska, A. Nikolajuk et al., “Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity,” Clinical Endocrinology, vol. 76, no. 1, pp. 46–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Hellemons, M. Mazagova, R. T. Gansevoort et al., “Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes,” Diabetes Care, vol. 35, no. 11, pp. 2340–2346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Dostálová, T. Roubíček, M. Bártlová et al., “Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet,” European Journal of Endocrinology, vol. 161, no. 3, pp. 397–404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Herder, M. Carstensen, and D. M. Ouwens, “Anti-inflammatory cytokines and risk of type 2 diabetes,” Diabetes, Obesity & Metabolism, vol. 15, supplement 3, pp. 39–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Hong, H. K. Chung, H. Y. Park et al., “GDF15 is a novel biomarker for impaired fasting glucose,” Diabetes & Metabolism Journal, vol. 38, no. 6, pp. 472–479, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Carstensen, C. Herder, E. J. Brunner et al., “Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study,” European Journal of Endocrinology, vol. 162, no. 5, pp. 913–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. H. Hong, Y.-K. Choi, B.-K. Min et al., “Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment,” Diabetes Research and Clinical Practice, vol. 109, no. 1, pp. 64–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Rishi, D. F. Wallace, and V. N. Subramaniam, “Hepcidin: regulation of the master iron regulator,” Bioscience Reports, vol. 35, no. 3, Article ID e00192, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  26. A. S. Levey, R. L. Berg, J. J. Gassman, P. M. Hall, and W. G. Walker, “Creatinine filtration, secretion and excretion during progressive renal disease,” Kidney International, vol. 36, no. 27, pp. S73–S80, 1989. View at Google Scholar · View at Scopus
  27. B. B. Yeap, M. L. Divitini, J. E. Gunton et al., “Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis,” Clinical Endocrinology, vol. 82, no. 4, pp. 525–532, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Jiang, Z.-Z. Sun, Y.-T. Tang, C. Xu, and X.-Y. Jiao, “Hepcidin expression and iron parameters change in Type 2 diabetic patients,” Diabetes Research and Clinical Practice, vol. 93, no. 1, pp. 43–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. A. Yegin, O. T. Iyidir, C. Demirtaş et al., “The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders,” Journal of Endocrinological Investigation, vol. 38, no. 3, pp. 333–338, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. J. W. Kim, K. M. Kang, T. K. Yoon, S. H. Shim, and W. S. Lee, “Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 102, no. 2, pp. 548–554.e2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Jiang, W.-J. Yu, X.-H. Wang, Y.-T. Tang, L. Guo, and X.-Y. Jiao, “Regulation of hepcidin through GDF-15 in cancer-related anemia,” Clinica Chimica Acta, vol. 428, pp. 14–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Vila, M. Riedl, C. Anderwald et al., “The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients,” Clinical Chemistry, vol. 57, no. 2, pp. 309–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Li, L. Yang, W. Qin, G. Zhang, J. Yuan, and F. Wang, “Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus,” PLoS ONE, vol. 8, no. 6, Article ID e65549, 2013. View at Publisher · View at Google Scholar · View at Scopus